Bayer : Unbureaucratic relief -- Bayer helping people affected by the earthquake in Mexico -- The company is providing EUR 268,000 in medicine as part of its disaster relief program

Leverkusen, September 29, 2017- As part of its disaster relief program, Bayer is donating medicines worth EUR 268,000 to the victims of the major earthquake that struck Mexico. This aid will offer speedy and unbureaucratic relief to the people affected by this tragedy in Central America. The medicines will be sent to the non-profit organization Direct Relief for distribution to people injured in the quake. Direct Relief is a long-term strategic partner of Bayer that provides assistance and medical supplies around the world to regions torn by crisis and areas with limited medical access. Mexico City was hit by a magnitude 7.1 earthquake on September 19, 2017, and hundreds of people perished.

Providing disaster relief is part of Bayer's social commitment. The company follows a dual strategy to help people affected by acute hardship: When disaster strikes, Bayer provides immediate assistance - either by donating money and medicines or making material donations to help rebuild infrastructure. In addition, Bayer AG's charitable foundation, the Bayer Cares Foundation, supports long-term reconstruction projects.

In 2017, Bayer has already provided support to projects in the following nine regions affected by disasters: The Brazilian organization Mundo Positivo received a donation of EUR 203,000 to implement a preventive program in the state of Pernambuco, which has been hit by the Zika virus. The Canadian Red Cross received EUR 14,000 to combat devastating wildfires in rural areas. The organization Direct Relief and the American Red Cross received EUR 93,000 each to provide rapid assistance to people in the U.S. state of Texas, one of the areas hit by Hurricane Harvey. The Chilean fire service received EUR 92,000 to initiate a family protection program. Medicines were donated to the CDC Foundation for distribution to young women attending prenatal visits in Puerto Rico, one of the countries affected by the Zika virus (worth EUR 56,000); the Colombian Civil Air Patrol to assist people affected by flooding in Mocoa (EUR 24,000); and U.S. animal welfare organizations to help care for pets and livestock injured by Hurricane Harvey (EUR 24,000). The Nigerian Ministry of Agriculture also received plant protection products worth EUR 30,000 for smallholder farmers to use to treat crops infested with armyworm moths. In total, eight projects have now received donations of money or products totaling around EUR 915,000.

Bayer Cares Foundation
As the social welfare foundation of the innovation company Bayer, the Bayer Cares Foundation sees itself especially as an initiator, promoter and partner for innovation at the interface between industry and the social sector. The sponsorship programs are focused on people - their commitment to public welfare, their wealth of ideas in fulfilling social needs, as well as those that arise in times of emergency. The foundation's funding activities are a central element of Bayer's global social commitment amounting to approximately EUR 50 million annually - with the focus on promoting scientific education and leading-edge research, and on providing health care and meeting the basic social needs of people who live near the company's sites.

For further information on the Bayer Cares Foundation, please visit:www.bayer-foundations.com

For social media users:
Visit Bayer on Facebook at:www.facebook.com/Bayer
Follow us on Twitter at:www.twitter.com/Bayer

Find more information atwww.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website atwww.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.